Expression of adhesion molecules on human hematopoietic progenitor cells at different maturational stages

Stem Cells
M KobayashiT Miyazaki

Abstract

In this report we examined the expression of several adhesion molecules on human hematopoietic progenitor cells at different maturational stages. Human hematopoietic progenitor cell-enriched fractions were prepared from bone marrow cells by depleting lymphocytes and monocytes (CD2+, CD14+ and CD19+ cells). These cells were separated into adhesion molecule-positive and -negative cell populations by immunomagnetic separation methods and then assessed for their ability to form various colony forming cells (CFC). CD44 and CD49d were expressed on multipotent hematopoietic progenitor cells, or mixed colony forming units (CFU-Mix), erythroid burst forming units (BFU-E), granulocyte-macrophage CFU (CFU-GM) and erythroid CFU (CFU-E). Leu8 was expressed on CFU-Mix, BFU-E and some populations of CFU-GM, but not CFU-E. CD11a was expressed on some populations of CFU-Mix, CFU-GM and BFU-E. CD54 was expressed only on some populations of CFU-GM. These results suggest that Leu8, CD44, CD49d and CD11a appear to play important roles in the differentiation and proliferation of human hematopoietic progenitor cells at different maturational stages in the bone marrow microenvironment.

References

Oct 1, 1992·Annals of Hematology·M A Reuss-BorstC A Müller
Feb 1, 1990·The Journal of Experimental Medicine·K MiyakeP W Kincade
Jun 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·W M GallatinW G Carter
Jan 1, 1989·Advances in Immunology·T A Yednock, S D Rosen
Feb 1, 1988·British Journal of Haematology·M Y Gordon

❮ Previous
Next ❯

Citations

Aug 26, 2009·Bulletin of Experimental Biology and Medicine·A P ZhambalovaL B Buravkova
Aug 8, 2001·Leukemia Research·S T LeeY W Ko
Nov 30, 2000·Proceedings of the National Academy of Sciences of the United States of America·C J DimitroffR Sackstein
Jan 1, 1997·British Journal of Haematology·S KhaldoyanidiM Zöller
Aug 23, 2000·Leukemia & Lymphoma·M Zoeller
May 23, 2006·Acta histochemica·Ulrika M SchadeUdo Schumacher
Oct 1, 1996·Differentiation; Research in Biological Diversity·L Y I
Jun 26, 2012·Biochimica Et Biophysica Acta·Jun XiaZhiwei Wang
Nov 21, 2000·American Journal of Obstetrics and Gynecology·D V SurbekW Holzgreve
Jun 18, 2002·Blood Cells, Molecules & Diseases·M Tarek Elghetany
Mar 21, 2001·The Journal of Cell Biology·J C AdamsA L Taylor
Jul 18, 2009·Stem Cells·Ashley L SiegelD D W Cornelison

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Adhesion Molecules in Health and Disease

Cell adhesion molecules are a subset of cell adhesion proteins located on the cell surface involved in binding with other cells or with the extracellular matrix in the process called cell adhesion. In essence, cell adhesion molecules help cells stick to each other and to their surroundings. Cell adhesion is a crucial component in maintaining tissue structure and function. Discover the latest research on adhesion molecule and their role in health and disease here.